NASDAQ
No price data available for this timeframe.
Karyopharm Therapeutics Inc. (KPTI) has a fcf yield of -93.65% as of Friday, May 29, 2026. This represents a 14.95% decrease compared to its 12-month average of -81.47%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.